Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer
Standard
Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer. / Tilki, Derya; Evans, Christopher P.
In: EUR UROL, Vol. 80, No. 4, 10.2021, p. 519-520.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
Tilki, D & Evans, CP 2021, 'Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer', EUR UROL, vol. 80, no. 4, pp. 519-520. https://doi.org/10.1016/j.eururo.2021.05.036
APA
Tilki, D., & Evans, C. P. (2021). Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer. EUR UROL, 80(4), 519-520. https://doi.org/10.1016/j.eururo.2021.05.036
Vancouver
Tilki D, Evans CP. Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer. EUR UROL. 2021 Oct;80(4):519-520. https://doi.org/10.1016/j.eururo.2021.05.036
Bibtex
@article{1648290a5c48483ca676e590ff9a4aa8,
title = "Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer",
keywords = "Gene Expression, Humans, Male, Prostatic Neoplasms/genetics",
author = "Derya Tilki and Evans, {Christopher P}",
year = "2021",
month = oct,
doi = "10.1016/j.eururo.2021.05.036",
language = "English",
volume = "80",
pages = "519--520",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",
}
RIS
TY - JOUR
T1 - Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer
AU - Tilki, Derya
AU - Evans, Christopher P
PY - 2021/10
Y1 - 2021/10
KW - Gene Expression
KW - Humans
KW - Male
KW - Prostatic Neoplasms/genetics
U2 - 10.1016/j.eururo.2021.05.036
DO - 10.1016/j.eururo.2021.05.036
M3 - Other (editorial matter etc.)
C2 - 34119382
VL - 80
SP - 519
EP - 520
JO - EUR UROL
JF - EUR UROL
SN - 0302-2838
IS - 4
ER -
